West Nile virus rates increased in 2021 compared to previous decade median in US surveillance

A descriptive surveillance report examined rates of West Nile virus and other nationally notifiable arboviral diseases in the United States population during 2021. The report compared 2021 data to the median rate observed during the 2010-2020 period. The main finding was that rates of West Nile virus increased in 2021, though specific effect sizes, absolute case numbers, and statistical measures were not reported. No comparator intervention or exposure was specified in this ecological surveillance data.

Safety and tolerability data for specific treatments were not reported, as this was a population-level disease surveillance report rather than a clinical trial. The report did not detail adverse events, serious adverse events, or discontinuations related to any medical interventions.

Key limitations include the observational, descriptive nature of the data, which cannot establish causality between any specific factors and the observed rate increase. The evidence represents association only. Generalizability is limited to the 2021 US surveillance context and cannot be extrapolated beyond this timeframe or geographic region without further study. Practice relevance is restrained to informing public health awareness; these findings do not provide guidance on individual patient management decisions.